Avitas Wealth Management’s BioNTech BNTX Stock Holding History

Avitas Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,231	Closed	-$833K	–	195
2021 Q4	$833K	Buy	3,231 +129	+4%	+$35.3K	0.14%	138
2021 Q3	$847K	Sell	3,102 -1,191	-28%	-$379K	0.15%	140
2021 Q2	$961K	Sell	4,293 -2,856	-40%	-$539K	0.17%	142
2021 Q1	$781K	Sell	7,149 -6,272	-47%	-$666K	0.15%	157
2020 Q4	$1.09M	Sell	13,421 -1,041	-7%	-$102K	0.22%	134
2020 Q3	$1M	Buy	14,462 +597	+4%	+$42.8K	0.28%	114
2020 Q2	$925K	Sell	13,865 -19,591	-59%	-$978K	0.31%	102
2020 Q1	$1.95M	Buy	+33,456	New	+$1.3M	0.89%	40

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Avitas Wealth Management's BNTX Position: Q1 2022 in Review

Avitas Wealth Management sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 3,231 shares — an estimated $833K sold.

Avitas Wealth Management first reported a position in BNTX in Q1 2020 and held it in 8 quarters. The position peaked at $1.95M in Q1 2020. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

Avitas Wealth Management reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
Avitas Wealth Management sold 3,231 BioNTech shares in Q1 2022, an estimated $833K.
Avitas Wealth Management first reported a position in BioNTech in Q1 2020 and held it in 8 quarters.
Avitas Wealth Management's BioNTech position peaked at $1.95M in Q1 2020.
287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Avitas Wealth Management's 13F filing for Q1 2022, filed 28 Apr 2022.